Safety and efficacy of uninterrupted treatment with edoxaban or warfarin during the peri‐procedural period of catheter ablation for atrial fibrillation

Safety and efficacy of uninterrupted treatment with edoxaban or warfarin during the peri‐procedural period of catheter ablation for atrial fibrillation

Abstract Background The real‐world safety and efficacy of uninterrupted anticoagulation treatment with edoxaban (EDX) or warfarin (WFR) during the peri‐procedural period of catheter ablation (CA) for atrial fibrillation (AF) are yet to be investigated. Methods We conducted a two‐center experience, o...

Full description

Bibliographic Details
Main Authors: Kazuya Naito, Masataka Nakano, Atsushi Iwasa, Yoshio Maeno, Yoshiaki Shintani, Takeshi Yamakawa, Kotaro Miyashita, Keishiro Oyama, Daisuke Nakai, Masaya Katagiri, Hideaki Kido, Shinichiro Masuda, Keiichi Kohashi, Tetsuya Kawamata, Shuzou Tanimoto, Naoki Masuda, Nobuhiko Ogata, Takaaki Isshiki
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Journal of Arrhythmia
Subjects:
atrial fibrillation
catheter ablation
edoxaban
uninterrupted anticoagulation
warfarin
Online Access:https://doi.org/10.1002/joa3.12351

Internet

https://doi.org/10.1002/joa3.12351

Similar Items